Search
for
Sort by
Research 61–90 of 1000+
- PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice
- Outcomes Associated With the Use of Finasteride: An Evaluation of this Medication as a Chemoprotective Agent and its Efficacy
- Finasteride
- Finasteride
- Combined C3b and Factor B Autoantibodies and MPGN Type II
- Proscar and Propecia—A Therapeutic Perspective
- Editorial Comment
- Prostatakarzinom
- Finasteride: not guilty after all?
- Editorial Comment
- Finasteride Doesn't Shorten Survival in Long-term Study
- Hair, Hormones, and High-Risk Prostate Cancer
- US Preterm Births: “D” Is for Dismal
- A Slippery Preventive Slope
- Abstract SS02-02: Chemoprevention: Poised for Success
- Focus sulla finasteride: efficacia, meccanismi e raccomandazioni per l'uso clinico
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
- Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents.
- French administrative health care database (SNDS): The value of its enrichment
- Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review.
- News & Notes
- Hormonal manipulation of benign prostatic hyperplasia
- Forum
- Treatment options for alopecia: an update, looking to the future
- Clinical use of 5α-reductase inhibitors
- New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics
- 5-Alpha Reductase Inhibitor Use and Prostate Cancer Prevention: A Victim of the Times?
- Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
- Prostate Cancer Early Detection, Version 2.2015